ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.331,39
-0,25%
S&P 500
5.469,30
0,39%
US Dollar vs BRL
5,4515
-0,01%
Bitcoin
61.671,61
-0,23%
Brent Oil
84,415
0,27%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Eidos Therapeutics Inc (EIDX)

  7. Eidos Therapeutics Inc (EIDX) Notícias

EIDX

Eidos Therapeutics (EIDX)

Eidos Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:EIDX
DataHoraFonteTítuloCódigoCompanhia
05/02/202118:32Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:EIDXEidos Therapeutics Inc
28/01/202108:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:EIDXEidos Therapeutics Inc
26/01/202118:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EIDXEidos Therapeutics Inc
26/01/202111:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:EIDXEidos Therapeutics Inc
26/01/202110:48Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:EIDXEidos Therapeutics Inc
26/01/202110:47Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EIDXEidos Therapeutics Inc
26/01/202110:30GlobeNewswire Inc.BridgeBio Pharma, Inc. Announces Completion of Merger with Eidos Therapeutics, Inc.NASDAQ:EIDXEidos Therapeutics Inc
19/01/202118:01GlobeNewswire Inc.Stockholders of BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Approve BridgeBio Pharma, Inc. Acquisition of Eidos Thera...NASDAQ:EIDXEidos Therapeutics Inc
13/01/202118:50Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EIDXEidos Therapeutics Inc
13/01/202118:30GlobeNewswire Inc.BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Announce January 21, 2021 Election Deadline for MergerNASDAQ:EIDXEidos Therapeutics Inc
04/01/202109:30GlobeNewswire Inc.Leading Independent Proxy Advisory Firm ISS Recommends BridgeBio Pharma and Eidos Therapeutics Stockholders Vote “FOR” Pr...NASDAQ:EIDXEidos Therapeutics Inc
15/12/202011:31Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:EIDXEidos Therapeutics Inc
05/11/202009:30GlobeNewswire Inc.BridgeBio Pharma, Inc. Reports Third Quarter 2020 Financial Results And Business UpdateNASDAQ:EIDXEidos Therapeutics Inc
29/10/202017:48Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EIDXEidos Therapeutics Inc
29/10/202017:30GlobeNewswire Inc.Eidos Therapeutics Reports Third Quarter 2020 Financial Results and Business UpdateNASDAQ:EIDXEidos Therapeutics Inc
05/10/202008:04GlobeNewswire Inc.BridgeBio Pharma and Eidos Therapeutics Announce Merger AgreementNASDAQ:EIDXEidos Therapeutics Inc
10/08/202020:24Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:EIDXEidos Therapeutics Inc
07/08/202017:30GlobeNewswire Inc.Eidos Therapeutics Appoints Industry Leaders With Significant Development and Commercial Expertise to Board of DirectorsNASDAQ:EIDXEidos Therapeutics Inc
06/08/202017:30GlobeNewswire Inc.Eidos Therapeutics Reports Second Quarter 2020 Financial Results and Business UpdateNASDAQ:EIDXEidos Therapeutics Inc
09/06/202017:01Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:EIDXEidos Therapeutics Inc
08/05/202017:30GlobeNewswire Inc.Eidos Therapeutics Reports First Quarter 2020 Financial Results and Business UpdateNASDAQ:EIDXEidos Therapeutics Inc
24/04/202017:09Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:EIDXEidos Therapeutics Inc
24/04/202017:06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:EIDXEidos Therapeutics Inc
08/04/202011:31Edgar (US Regulatory)Other FilingNASDAQ:EIDXEidos Therapeutics Inc
26/02/202018:43Edgar (US Regulatory)Annual Report (10-k)NASDAQ:EIDXEidos Therapeutics Inc
26/02/202018:30GlobeNewswire Inc.Eidos Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results and Business UpdateNASDAQ:EIDXEidos Therapeutics Inc
11/02/202014:58Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:EIDXEidos Therapeutics Inc
16/11/201920:58GlobeNewswire Inc.CORRECTION: BridgeBio and Eidos Present Data from Phase 2 Open Label Extension Suggesting Long-term Tolerability of AG10 and ...NASDAQ:EIDXEidos Therapeutics Inc
16/11/201919:30GlobeNewswire Inc.BridgeBio and Eidos Present Data from Phase 2 Open Label Extension Suggesting Long-term Tolerability of AG10 and Stabilizatio...NASDAQ:EIDXEidos Therapeutics Inc
31/10/201917:30GlobeNewswire Inc.Eidos Therapeutics Reports Third Quarter 2019 Financial Results and Business UpdateNASDAQ:EIDXEidos Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:EIDX

Seu Histórico Recente

COIN
LITHUSD
Lithium
BIT
F18673
Vontobel Financial Produ...
TG
2GQ
GFG Resources
USOTC
COVCF
Cover (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados